Knowledge Tree
pancreatic cancer
Also known as: pancreatic adenocarcinoma
Facts (12)
Sources
10 Breakthrough Research and Clinical Trials Shaping the ... honcology.com Dec 29, 2025 4 facts
claimHirschfeld Oncology integrates patient advocacy into its pancreatic cancer treatment model by ensuring patients are fully informed and actively involved in their care decisions.
claimHirschfeld Oncology employs a multidisciplinary team consisting of physicians, nurses, surgeons, and researchers to treat pancreatic cancer.
claimHirschfeld Oncology customizes chemotherapy intensity for pancreatic cancer patients by evaluating performance status, age, and nutritional health, including the use of dose-reduced regimens for frail patients.
claimDr. Azriel Hirschfeld utilizes Metronomic chemotherapy in pancreatic cancer treatment, a method involving the continuous administration of low-dose chemotherapy to maximize efficacy and reduce side effects.
Chronic Inflammation - StatPearls - NCBI Bookshelf ncbi.nlm.nih.gov 2 facts
claimChronic low-level inflammation participates in the development of many cancer types, including kidney, prostate, ovarian, hepatocellular, pancreatic, colorectal, lung, and mesothelioma.
referenceWeiss FU authored the review 'Pancreatic cancer risk in hereditary pancreatitis', published in Frontiers in Physiology in 2014.
Cellular senescence: from homeostasis to pathological implications ... frontiersin.org 2 facts
claimEZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance.
referenceTatekawa et al. (2022) reported in Scientific Reports that N6-methyladenosine methylation-regulated polo-like kinase 1 cell cycle homeostasis is a potential target of radiotherapy in pancreatic adenocarcinoma.
The breakthroughs behind UT MD Anderson's quest to end cancer nature.com 2 facts
claimNew research suggests that combining immunotherapies with KRAS-G12D inhibition may produce durable responses in pancreatic cancer, where immunotherapies alone have had little impact.
claimThe discovery of a protein closely involved with EGFR-KRAS signaling offers a potential method to thwart resistance pathways against RAS-targeted drugs in pancreatic cancer and other KRAS-associated tumors.
Our top cancer research breakthroughs of 2025 worldwidecancerresearch.org Nov 5, 2025 1 fact
claimProfessor Ruth Ganss, based in Australia, discovered that a new approach to drug dosage could assist in treating hard-to-treat cancers, specifically pancreatic cancer and glioblastoma.
Dietary interventions as regulators of stem cell behavior in ... genesdev.cshlp.org 1 fact
claimAlpha-ketoglutarate (αKG) accumulation acts as a prodifferentiation factor in several tissue types, including premalignant epidermal stem cells, intestinal stem cells, and pancreatic cancer cells.